New Delhi: The healthcare sector witnessed a worst hit amidst COVID-19 pandemic, thereby, driving the need for a contingency plan towards recovery and revival of the nation, says Dinesh Chauhan, CEO, CORE Diagnostics.
Sharing his expectations from budget 2022, Chauhan says, “Although healthcare has been a part of country’s development plan with comprehensive initiatives like Ayushman Bharat, National Digital Health Mission, Swasthya Suraksha Yojna and Mission Covid Suraksha and more, there is a need to allocate additional funds that would ensure universal health coverage to all, especially underprivileged.”
Chauhan adds, “While it was aptly reflected in the Union budget 2021 which demonstrated deep commitment towards the sector however, there is a lot more to be done. The pandemic has restored the fact that there is an urgent need to bolster innovative, tech-based, large-scale, and affordable healthcare solution in India to ensure quality treatment and cure, especially with the occurrence of the new variants. This requires significant investments in funding research and development sector, which ultimately need public-private partnership push to capture greater space in the heath sector.”
“Lastly, we expect the budget to bring in incentives to enable rapid growth of the sector, in addition to helping more people to get preventive screening and testing done at early stage,” Chauhan concludes.
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans